State of Wisconsin Investment Board
ALXN

State of Wisconsin Investment Board’s Alexion Pharmaceuticals ALXN Stock Holding History

State of Wisconsin Investment Board’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-562,635
Closed -$103M – 2206
2021
Q2 		$103M Buy
562,635
+158,580
+39% +$27.2M 0.21% 104
2021
Q1 		$61.8M Buy
404,055
+255,024
+171% +$39.4M 0.13% 176
2020
Q4 		$23.3M Sell
149,031
-148,492
-50% -$19.1M 0.05% 369
2020
Q3 		$34M Buy
297,523
+6,907
+2% +$745K 0.09% 242
2020
Q2 		$32.6M Buy
290,616
+62,536
+27% +$6.64M 0.09% 239
2020
Q1 		$20.5M Sell
228,080
-4,465
-2% -$438K 0.07% 301
2019
Q4 		$25.1M Sell
232,545
-2,325
-1% -$249K 0.06% 319
2019
Q3 		$23M Sell
234,870
-36,263
-13% -$4.09M 0.06% 323
2019
Q2 		$35.5M Sell
271,133
-32,434
-11% -$4.18M 0.1% 228
2019
Q1 		$41M Sell
303,567
-50,082
-14% -$6.23M 0.12% 192
2018
Q4 		$34.4M Buy
353,649
+29,480
+9% +$3.48M 0.11% 197
2018
Q3 		$45.1M Sell
324,169
-16,937
-5% -$2.12M 0.12% 164
2018
Q2 		$42.3M Sell
341,106
-35,811
-10% -$4.19M 0.12% 176
2018
Q1 		$42M Buy
376,917
+6,951
+2% +$831K 0.12% 173
2017
Q4 		$44.2M Buy
369,966
+122,712
+50% +$14.9M 0.12% 183
2017
Q3 		$34.7M Sell
247,254
-18,062
-7% -$2.45M 0.1% 220
2017
Q2 		$32.3M Buy
265,316
+127,020
+92% +$14.8M 0.1% 224
2017
Q1 		$16.8M Buy
138,296
+27,477
+25% +$3.54M 0.06% 346
2016
Q4 		$13.6M Sell
110,819
-20,365
-16% -$2.49M 0.06% 374
2016
Q3 		$16.1M Sell
131,184
-48,800
-27% -$6.28M 0.06% 341
2016
Q2 		$21M Sell
179,984
-52,640
-23% -$7.47M 0.08% 265
2016
Q1 		$32.4M Sell
232,624
-46,400
-17% -$6.81M 0.13% 181
2015
Q4 		$53.2M Buy
279,024
+87,900
+46% +$15.4M 0.2% 104
2015
Q3 		$29.9M Sell
191,124
-34,561
-15% -$6.3M 0.12% 202
2015
Q2 		$40.8M Buy
225,685
+75,491
+50% +$13M 0.14% 163
2015
Q1 		$26M Sell
150,194
-23,010
-13% -$4.16M 0.09% 268
2014
Q4 		$32M Buy
173,204
+8,800
+5% +$1.63M 0.11% 223
2014
Q3 		$27.3M Buy
164,404
+980
+0.6% +$161K 0.1% 247
2014
Q2 		$25.5M Sell
163,424
-20,080
-11% -$3.17M 0.09% 265
2014
Q1 		$27.9M Buy
183,504
+200
+0.1% +$31.8K 0.11% 221
2013
Q4 		$24.4M Sell
183,304
-10,190
-5% -$1.22M 0.09% 251
2013
Q3 		$22.5M Sell
193,494
-51,120
-21% -$5.61M 0.09% 254
2013
Q2 		$22.6M Buy
+244,614
New +$23.6M 0.09% 255

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

State of Wisconsin Investment Board's ALXN Position: Q3 2021 in Review

State of Wisconsin Investment Board sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 562,635 shares — an estimated $103M sold.

State of Wisconsin Investment Board first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $103M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • State of Wisconsin Investment Board reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 562,635 Alexion Pharmaceuticals shares in Q3 2021, an estimated $103M.
  • State of Wisconsin Investment Board first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • State of Wisconsin Investment Board's Alexion Pharmaceuticals position peaked at $103M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2021, filed 12 Nov 2021.